In a report released today, Peter Welford from Jefferies downgraded GlaxoSmithKline (GSK – Research Report) to a Hold, with a price ...

US-based investment firm takes controlling stake in Opella, while France's government moves to ensure the company remains in ...

Sanofi announced that it has entered into exclusive negotiations with the US private equity firm Clayton, Dubilier & Rice (CD&R) to transfer around 50% controlling stake in Opella.

The print ads featured a prominent display of a person’s back, highlighting where shingles rashes typically emerge.

Mumbai: On 12 November 2024, Fireside Ventures, an early-stage venture fund focused on consumer brands, appointed Adarsh ...

GSK CEO Emma Walmsley's bet on blockbuster RSV vaccine, Arexvy, has hit a snag in recent months after the U.S. public health ...

Shalini Kumar has joined Kenvue as Head - Consumer Experience. Shalini was earlier with Halenon as Area Media Lead for ...

Mehta said HUL's focus would continue to ensure uninterrupted supplies of COVID relevant portfolio and meeting the demand arising out of evolving consumer needs ...

GSK spun off Haleon to form a new consumer healthcare entity, driven by activist investor pressure and its underperforming share price. Haleon’s financials show steady growth with 2023 revenues ...

The Oral Hygiene market presents a robust growth outlook with evolving consumer preferences ... Johnson & Johnson, Unilever, ...

Glaxo uses joint ventures to gain additional scale in certain markets like HIV and consumer products. Read More on GB:GSK: GSK NewsMORE Related Stocks Indices ...

GSK cuts 2024 vaccine sales forecast for second time this year Strong specialty medicines offset lower vaccine sales - CEO Q3 EPS beats market expectations Shares down 3.9% at 0958 GMT Oct 30 ...